Avid Bioservices Inc (CDMO)

[freethemice]

Who is Harold F. Dvorak, MD?
Mallinckrodt Distinguished Professor of Pathology, Department of Pathology, Harvard Medical School
Chief, Pathology, Beth Israel Deaconess Medical Center
National Foundation for Cancer Research Fellow
2006 Albert Szent-Györgyi Prize winner
http://www.nfcr.org/research/197-harold-f-dvorak-md
Dr. Dvorak was awarded NFCR's Inaugural Annual Albert Szent- Györgyi Prize for Progress in Cancer Research for his groundbreaking discoveries of VEGF and its profound influence in the development of new anti-cancer therapies.

"Dr. Dvorak's breakthrough had a major influence on the research efforts of many other vascular scientists, and this has led to the development of anti-angiogenic drugs that target VEGF such as AvastinTM by the company GENENTECH. Avastin is the trade name for Bevacizumab and is a monoclonal antibody that recognizes all vascular endothelial growth factor isoforms and blocks angiogenesis. Bevacizumab was the first clinically available angiogenesis inhibitor in the United States."

Do a PubMed search and you will find 300 papers that he has authored or co-authored.

SCIENTIFIC ADVISOR PEREGRINE PHARMACEUTICALS
http://www.peregrineinc.com/about-us/medical-and-scientific-advisors.html